Citigroup Inc Aprea Therapeutics, Inc. Transaction History

Citigroup Inc

  • $163 Billion
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022
SELL
$0.62 - $1.94 $310 - $970
-500 Closed
0 $0
Q1 2022

May 12, 2022
BUY
$1.59 - $3.16 $795 - $1,580
500 New
500 $1,000
Q4 2021

Feb 10, 2022
SELL
$2.87 - $5.58 $3,179 - $6,182
-1,108 Closed
0 $0
Q3 2021

Nov 10, 2021
BUY
$3.43 - $5.63 $3,800 - $6,238
1,108 New
1,108 $6,000

Others Institutions Holding APRE

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About Aprea Therapeutics, Inc.

APRE Quotes by TradingView
  • Ticker APRE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Description
  • Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products...
More about APRE
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email